Orthofix Medical Inc.

NasdaqGS:OFIX Stock Report

Market Cap: US$609.8m

Orthofix Medical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:OFIX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Oct 25BuyUS$5,711,991Juniper Investment Company, LLCCompany398,178US$15.24
25 Sep 25BuyUS$5,345,561Juniper Investment Company, LLCCompany375,780US$14.74
18 Aug 25SellUS$28,363Patrick FisherIndividual1,996US$14.21
02 Jul 25BuyUS$13,881Engine Capital Management, LPCompany1,250US$11.11
18 Jun 25SellUS$39,181Aviva McPherronIndividual3,728US$10.51
11 Jun 25SellUS$19,125Max ReinhardtIndividual1,643US$11.64
04 Jun 25BuyUS$24,570Alan BazaarIndividual2,250US$10.92
12 May 25BuyUS$50,292Alan BazaarIndividual3,990US$12.62
09 May 25BuyUS$125,400Massimo CalafioreIndividual10,000US$12.54
07 May 25BuyUS$1,231,000Engine Capital Management, LPCompany100,000US$12.31
06 May 25BuyUS$8,969,161Engine Capital Management, LPCompany523,444US$17.13
16 Apr 25SellUS$50,791J. CedronIndividual3,816US$13.31
09 Apr 25BuyUS$6,867,127Juniper Investment Company, LLCCompany431,251US$16.10
02 Apr 25SellUS$1,196Geoffrey GillespieIndividual76US$15.74
18 Mar 25SellUS$71,164Lucas VitaleIndividual4,287US$16.60
18 Mar 25SellUS$4,914Geoffrey GillespieIndividual296US$16.60
05 Mar 25BuyUS$172,801Massimo CalafioreIndividual9,914US$17.43
27 Feb 25BuyUS$3,027,818Engine Capital Management, LPCompany177,483US$17.13
04 Feb 25SellUS$17,026Geoffrey GillespieIndividual954US$18.08
16 Jan 25SellUS$83,278Julie AndrewsIndividual4,655US$17.89
13 Jan 25SellUS$327,376Massimo CalafioreIndividual19,281US$17.14
08 Jan 25SellUS$8,117Geoffrey GillespieIndividual476US$17.14
31 Dec 24BuyUS$1,812,859Juniper Investment Company, LLCCompany101,089US$19.22
17 Dec 24SellUS$464Geoffrey GillespieIndividual26US$17.84

Insider Trading Volume

Insider Buying: OFIX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of OFIX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders485,8911.23%
General Public2,328,3785.9%
Hedge Funds14,195,92035.9%
Institutions22,484,07656.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 82.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.8%
Engine Capital Management, LP
4,252,921US$65.7m0.03%10.57%
9.42%
Rubric Capital Management LP
3,721,715US$57.5m0.72%0.75%
8.46%
Paradigm Capital Management, Inc.
3,340,600US$51.6m34.6%2.07%
8.21%
Juniper Investment Company, LLC
3,243,284US$50.1m31.3%15.91%
8.13%
BlackRock, Inc.
3,211,551US$49.6m4.88%no data
7.54%
Armistice Capital LLC
2,978,000US$46.0m0.47%1.23%
5.93%
The Vanguard Group, Inc.
2,342,254US$36.2m7.38%no data
2.72%
Dimensional Fund Advisors LP
1,073,949US$16.6m32.2%no data
2.4%
State Street Global Advisors, Inc.
947,282US$14.6m10.1%no data
2.39%
Ayal Capital Advisors Limited
943,203US$14.6m74.7%7.11%
2.36%
Geode Capital Management, LLC
930,252US$14.4m7.49%no data
2.14%
Philosophy Capital Management LLC
845,280US$13.1m128%1.58%
2%
Millennium Management LLC
790,868US$12.2m1,070%0.01%
1.72%
Bank of America Corporation
678,910US$10.5m650%no data
1.19%
Renaissance Technologies LLC
469,201US$7.2m410%0.01%
1.07%
GAMCO Investors, Inc.
423,123US$6.5m37.6%0.02%
0.93%
Northern Trust Global Investments
367,244US$5.7m4.88%no data
0.88%
UBS Asset Management AG
346,326US$5.3m183%no data
0.71%
Charles Schwab Investment Management, Inc.
281,085US$4.3m0%no data
0.69%
Jacobs Levy Equity Management Inc
270,978US$4.2m322%0.02%
0.66%
Soleus Capital Management, L.P.
261,147US$4.0m-56.6%0.19%
0.53%
Morgan Stanley
207,747US$3.2m13.4%no data
0.49%
Great Lakes Advisors, LLC
194,265US$3.0m0%0.02%
0.49%
JPMorgan Chase & Co.
193,434US$3.0m15.6%no data
0.48%
RBC Dominion Securities Inc.
188,464US$2.9m294,000%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/02 08:46
End of Day Share Price 2025/10/31 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Orthofix Medical Inc. is covered by 15 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael PetuskyBarrington Research Associates, Inc.
Caitlin CroninCanaccord Genuity
David TurkalyCitizens JMP Securities, LLC